Eye Drops
Eye Drops - Related Videos
09:03
Trabecular Meshwork Response to Pressure Elevation in the Living Human Eye
0 Views •
Cited by 7 •
2015
Trabecular meshwork (TM) migration into Schlemm’s canal space can be induced by acute pressure elevation by ophthalmodynamometer, and observed by spectral domain optical coherence tomography. The goal of this method is to quantify the morphometric response of the living outflow tract to acute pressure elevation in living tissues in situ.
09:20
Picoinjection of Microfluidic Drops Without Metal Electrodes
0 Views •
Cited by 2 •
2014
We have developed a technique for picoinjecting microfluidic drops that does not require metal electrodes. As such, devices incorporating our technique are simpler to fabricate and to use.
08:57
The Preparation of Drosophila Embryos for Live-Imaging Using the Hanging Drop Protocol
0 Views •
Cited by 34 •
2009
A simple, inexpensive, and effective method of preparing Drosophila embryos for live-imaging analysis is presented. Our protocol provides humidity and gas exchange and does not compress the Drosophila embryo. This method is suitable for GFP-based live imaging of Drosophila embryos using a stereomicroscope or upright compound microscope.
01:13
Excess Pressure Inside a Drop and a Bubble
0 Views •
2023
The shape of a small drop of liquid can be considered spherical, neglecting the effect of gravity. This drop can further be considered as two equal hemispherical drops put together due to surface tension. The forces acting on the spherical drop are due to the pressure of the liquid inside the drop, the pressure due to air outside the drop, and the force due to the surface tension acting on the two hemispherical drops. where γ corresponds to the surface tension. Recalling that the force per...
08:13
In Vivo Confocal Microscopy in the Diagnosis and Management of Dry Eye: A Focus on Imaging Protocols and Interpretation
0 Views •
2025
This article demonstrates the operation and effect of in vivo confocal microscopy in the diagnosis and treatment of dry eye and investigates the application and outcomes of in vivo confocal microscopy to provide a basis for future research.
FAQs
After instillation, the drug mixes with the tear film, where dilution can reduce its concentration and contact time. Excess liquid may drain through the nasolacrimal duct, limiting exposure at ocular tissues. Pharmacology studies therefore consider formulation, retention on the eye, tear dilution, and drainage together when assessing how much medication can act on the cornea, conjunctiva, or anterior eye.
Formulation influences how long an eye drop remains in contact with the ocular surface and how much active ingredient reaches the intended site. Because exposure depends partly on contact time and tear dilution, researchers can compare formulations by examining ocular retention and resulting effectiveness. This relationship is important when designing therapies intended to improve local drug delivery.
The active ingredient determines the principal therapeutic outcome and may target different ocular needs. Some ingredients reduce inflammation, others lower intraocular pressure, treat infection, or relieve dryness. Their effects also depend on where the formulation acts, such as the cornea, conjunctiva, or anterior eye, making both drug choice and ocular site relevant to treatment design.
Sterility and preservatives are formulation considerations that support safer ocular treatment, alongside the drug’s pharmacological activity. Researchers evaluating an eye drop must consider not only whether the active ingredient produces the intended effect, but also whether the formulation is appropriate for ocular use. These factors belong to the broader assessment of safety, effectiveness, and product design.
Pharmacologists can assess how formulation and dosing technique affect ocular drug exposure, retention, and therapeutic effectiveness. Depending on the active ingredient, outcomes may include reduced inflammation, lower intraocular pressure, treatment of infection, or relief of dryness. These measures connect pharmacokinetic behavior at the eye surface with clinically relevant pharmacological effects.
A dosing approach should account for how the formulation spreads across the tear film, how long it remains in contact with ocular tissues, and how much is lost through tear dilution or nasolacrimal drainage. Dosing technique also matters for safer treatment. Together, these considerations help researchers evaluate whether the intended ocular exposure and therapeutic outcome are achievable.
Ocular pharmacokinetic evaluation examines the movement and persistence of medication after instillation. Researchers consider formulation, tear-film contact time, dilution, and drainage, then relate these factors to activity in the cornea, conjunctiva, or anterior eye. This approach helps explain differences in effectiveness and guides the design of formulations with improved ocular retention.
Researchers select eye drops when they need to deliver medication locally to the eye or provide lubrication. Studies may focus on anti-inflammatory treatment, intraocular-pressure reduction, infection treatment, or relief of dryness. The method is also useful for investigating how formulation and administration affect ocular exposure, making it relevant to both therapeutic development and routine ocular care.